West Nile Virus and Other Arboviral Diseases — United States, 2012
暂无分享,去创建一个
[1] C. Umscheid,et al. PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission through Organ Transplantation , 2013, Public health reports.
[2] M. Golden,et al. Evidence for the Long-Term Stability of HIV Transmission–Associated Sexual Behavior After HIV Diagnosis , 2013, Sexually transmitted diseases.
[3] C. Whitney,et al. Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2013, MMWR. Morbidity and mortality weekly report.
[4] E. Emini,et al. A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study , 2012 .
[5] Lei Wang,et al. Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.
[6] T. Lieu,et al. Healthcare utilization and cost of pneumococcal disease in the United States. , 2011, Vaccine.
[7] P. Phanuphak,et al. Active Voluntary Counseling and Testing With Integrated CD4 Count Service Can Enhance Early HIV Testing and Early CD4 Count Measurement: Experiences From the Thai Red Cross Anonymous Clinic in Bangkok, Thailand , 2011, Journal of acquired immune deficiency syndromes.
[8] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[9] C. Whitney,et al. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[10] W. Schaffner,et al. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization , 2010, AIDS.
[11] Praphan Phanuphak,et al. Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010 , 2010 .
[12] M. Noble,et al. Solid organ transplantation and the probability of transmitting HIV, HBV, or HCV; a systematic review to support an evidence-based guideline , 2010 .
[13] M. Molyneux,et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. , 2010, The New England journal of medicine.
[14] P. Phanuphak,et al. Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003–2007 , 2010, Journal of acquired immune deficiency syndromes.
[15] P. Sullivan,et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. , 2009, Annals of epidemiology.
[16] P. F. Adams,et al. Summary health statistics for the U.S. population: National Health Interview Survey, 2007. , 2008, Vital and health statistics. Series 10, Data from the National Health Survey.
[17] Jerome H. Kim,et al. Incidence and Characterization of Acute HIV-1 Infection in a High-Risk Thai Population , 2008, Journal of acquired immune deficiency syndromes.
[18] M. Farley,et al. Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life , 2008, Pediatrics.
[19] W. Borkowsky,et al. Immunogenicity, Safety, and Predictors of Response After a Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine Series in Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy , 2006, The Pediatric infectious disease journal.
[20] S. Madhi,et al. Quantitative and Qualitative Antibody Response to Pneumococcal Conjugate Vaccine Among African Human Immunodeficiency Virus-Infected and Uninfected Children , 2005, The Pediatric infectious disease journal.
[21] S. Madhi,et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. , 2003, The New England journal of medicine.
[22] S. Blanchard,et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. , 2003, Pediatrics.
[23] L. Sehulster,et al. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[24] P. Kilmarx,et al. Explosive spread and effective control of human immunodeficiency virus in northernmost Thailand: the epidemic in Chiang Rai province, 1988–99 , 2000, AIDS.
[25] R. Moseley,et al. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs , 1994 .
[26] William Schaffner,et al. Nosocomial transmission of Salmonella gastroenteritis to laundry workers in a nursing home. , 1994 .